Invention Grant
US09198879B2 Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA)
有权
用于去甲二氢瓜亚辛酸（NDGA）的药理学优化的多模式药物递送系统
- Patent Title: Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA)
- Patent Title (中): 用于去甲二氢瓜亚辛酸（NDGA）的药理学优化的多模式药物递送系统
-
Application No.: US13911893Application Date: 2013-06-06
-
Publication No.: US09198879B2Publication Date: 2015-12-01
- Inventor: Pravin R. Chaturvedi
- Applicant: Napo Pharmaceuticals, Inc.
- Applicant Address: US CA San Francisco
- Assignee: NAPO PHARMACEUTICALS, INC.
- Current Assignee: NAPO PHARMACEUTICALS, INC.
- Current Assignee Address: US CA San Francisco
- Agency: Troutman Sanders, LLP
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/05 ; A61K9/00
Abstract:
The present invention relates generally to compositions and methods for oral delivery of nordihydroguaiaretic acid (NDGA). More particularly, the present invention relates to pharmacologically optimized multimodal drug delivery systems for orally administered NDGA and methods for preparation and use thereof.
Public/Granted literature
- US20130274346A1 PHARMACOLOGICALLY OPTIMIZED MULTIMODAL DRUG DELIVERY SYSTEM FOR NORDIHYDROGUIARETIC ACID (NDGA) Public/Granted day:2013-10-17
Information query
